ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

ANI Pharma (ANIP) Misses Q4 EPS by 20c

March 15, 2022 6:52 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q4 EPS of $0.54, $0.20 worse than the analyst estimate of $0.74. Revenue for the quarter came in at $60.9 million versus the consensus estimate of $56.3 million.

GUIDANCE:

ANI Pharma sees FY2022 revenue of $260-275 million, versus the consensus... More